Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* ASD less than or equal to 17 mm.~Exclusion Criteria:~* Conditions that would confound treatment of ASD or complicate distinguishing onset of adverse events.~* Unable to accommodate device delivery catheter.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Test Device (Type: EXPERIMENTAL): ASD closure with the GORE® CARDIOFORM Septal Occluder

Based on this trial design, predict the completion outcome and termination type (if applicable).